Skip to main content
SUNDRUG CO.,LTD. logo

SUNDRUG CO.,LTD. — Investor Relations & Filings

Ticker · 9989 ISIN · JP3336600006 T Wholesale and retail trade
Open in API
Filings indexed 60 across all filing types
Latest filing 2025-11-14 Report Publication Anno…
Country JP Japan
Listing T 9989

About SUNDRUG CO.,LTD.

https://www.sundrug.co.jp/

SUNDRUG CO.,LTD. operates a chain of drugstores, dispensing pharmacies, and discount stores. The company's activities are organized into two primary segments: the Drug Store Business and the Discount Store Business. It engages in the retail and wholesale of a wide range of products, including pharmaceuticals, cosmetics, and daily necessities. In addition to its corporate-owned stores, SUNDRUG provides products and business guidance to franchise and voluntary chain stores. The company manages various store formats and brands within its group and also operates an e-commerce platform.

Recent filings

Filing Released Lang Actions
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (Kakuninsho) filed under the Financial Instruments and Exchange Act in Japan, specifically confirming the accuracy of the contents of a Semi-Annual Report (Hankihokokusho). Since this is a regulatory filing confirming the validity of a report rather than the report itself, and it does not fit into specific categories like 10-K or IR, it falls under the general regulatory filing category.
2025-11-14 Japanese
半期報告書－第63期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Semi-Annual Report' (半期報告書) filed by Sundrug Co., Ltd. with the Kanto Local Finance Bureau in Japan. It covers the interim accounting period from April 1, 2025, to September 30, 2025. It contains comprehensive financial statements, including the balance sheet, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2026
2025-11-14 Japanese
臨時報告書
AGM Information Classification · 100% confidence The document is titled '臨時報告書' (Extraordinary Report) and is submitted to the Kanto Local Finance Bureau. Section 1 explicitly states the reason for filing is that resolutions were passed at the '定時株主総会' (Annual General Meeting) held on June 20, 2025, pursuant to Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act. Section 2 details the resolutions, including the approval of the surplus appropriation and the election of 7 directors, along with the voting results (votes for, against, abstentions). This content perfectly matches the definition of reporting the results of a shareholder meeting, which corresponds to the 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to the AGM, the specific focus on reporting the *results* of the vote makes DVA more precise than AGM-R (which is for presentations/materials).
2025-06-25 Japanese
内部統制報告書－第62期(2024/04/01－2025/03/31)
Governance Information Classification · 100% confidence The document header explicitly states the filing type as "内部統制報告書" (Internal Control Report) and cites the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の４の４第１項). This type of report, which assesses the effectiveness of internal controls over financial reporting, corresponds to the requirements often associated with the US SEC's Sarbanes-Oxley Act Section 404 reporting, which is typically filed as part of the annual 10-K, but when filed standalone or specifically titled as an internal control report in a Japanese context, it aligns best with the comprehensive annual reporting structure or a specific audit/control assessment. Given the options, this document is a formal report detailing the assessment of internal controls, which is a key component of comprehensive annual reporting or a standalone audit/control report. Since it is a detailed report on internal control assessment, it is closely related to the 'Audit Report / Information' (AR) category, which covers applied accounting principles and results of internal/regulatory stress tests, or the comprehensive annual report (10-K). However, the specific nature of 'Internal Control Report' in the Japanese regulatory context is a distinct, required filing. Comparing the definitions, 'AR' (Audit Report / Information) is the closest fit for a formal, detailed assessment of controls and principles, distinct from the full '10-K' which is the overall annual report. Given the explicit title, it is a formal control assessment report.
2025-06-19 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is extremely short (590 characters) and contains a header section typical of Japanese regulatory filings, specifically mentioning "【提出書類】確認書" (Filing Document: Confirmation Document) and referencing the Financial Instruments and Exchange Act ("金融商品取引法"). The core content confirms that the CEO has verified the appropriateness of the contents of the company's Annual Securities Report ("有価証券報告書") for the fiscal year ending March 31, 2025. This type of confirmation document, which attests to the accuracy of a primary report (like a 10-K equivalent), is a specific regulatory filing. Given the options, it is not the full Annual Report (10-K), nor is it a standard Earnings Release (ER) or Interim Report (IR). It is a specific regulatory confirmation/attestation. Since there is no specific code for a 'Confirmation of Securities Report Accuracy,' and it is a formal regulatory document, the most appropriate general category among the provided specific codes is 'Regulatory Filings' (RNS), as it is a mandatory regulatory submission that doesn't fit the other specialized categories like DIRS, DIV, or MANG. However, if we strictly interpret the content as an attestation related to the Annual Report, it is a specific regulatory filing, but not the report itself. Given the structure and content, it functions as a mandatory regulatory submission. FY 2025
2025-06-19 Japanese
有価証券報告書－第62期(2024/04/01－2025/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the header information for the fiscal year ending March 31, 2025, including the company name (Sundrug Co., Ltd.), the filing date (June 19, 2025), and the legal basis (Financial Instruments and Exchange Act). The document structure and metadata confirm it is the comprehensive annual financial report. FY 2025
2025-06-19 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.